Loading...
NPI 1316463813 · Pittsfield, MA · Mobile Radiology Clinic/Center
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Shields Pet Ct At Berkshire Medical Center LLC is a mobile radiology clinic/center provider located in Pittsfield, Massachusetts. This profile covers 4 Medicare and 2 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Shields Pet Ct At Berkshire Medical Center LLC |
| Address | 165 Tor Ct |
| City | Pittsfield |
| State | MA |
| ZIP | 01201 |
| Taxonomy | Mobile Radiology Clinic/Center |
| NPI Enumerated | August 16, 2017 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $1.7M |
| Medicaid | $829.9K |
This entity presents as a mobile PET/CT imaging operation: its top Medicare and Medicaid revenue drivers are imaging and radiopharmaceutical codes (78815, A9595, A9552), consistent with the listed taxonomy Mobile Radiology Clinic/Center. The code mix—combining high-volume PET/CT imaging (78815) with diagnostic radiotracer supplies (A9595, A9552)—indicates the business both performs imaging studies and bills for the associated tracers used in those studies.
Revenue is highly concentrated by a small set of services on both payers: the precomputed top 3 Medicare codes account for 94.2% of the provider's Medicare revenue, and the precomputed top 3 Medicaid codes account for 100.0% of the provider's Medicaid revenue. This concentration means a few PET/CT and tracer codes dominate financial performance for each payer.
The provider draws more revenue from Medicare than Medicaid: reported lifetime Medicare revenue is $1.7M versus lifetime Medicaid revenue of $829.9K. Both payers are material to the practice’s volume and revenue profile, so changes in either payer’s PET/CT or tracer coverage could noticeably affect total revenue.
On Medicare this provider is a national volume leader for several PET-related codes: 78815 is reported as an "extreme outlier" nationally (rank #99 of 6566, 99th percentile) and A9552 is also an "extreme outlier" (rank #30 of 2411, 99th percentile). A9595 is reported at rank #48 of 528 (91th percentile; described as typical, unremarkable), so the provider combines two exceptionally high-volume national positions with one more typical tracer volume rank.
By contrast, the provider’s Medicaid position is more typical within Massachusetts: 78815 ranks #15 of 49 in-state (71th percentile; typical, unremarkable) and A9552 ranks #10 of 33 in-state (72th percentile; typical, unremarkable). These in-state ranks suggest the provider is a regular participant in the state PET/CT market but not a dominant statewide outlier for Medicaid volumes.
Reimbursement levels show a substantial per-claim gap between Medicare and Medicaid for the same imaging services: 78815 averages $1325 paid/claim on Medicare versus $452 paid/claim on Medicaid, and A9552 averages $414 paid/claim on Medicare versus $182 paid/claim on Medicaid. The provider also reports A9595 on Medicare with an average paid/claim of $484, indicating it bills higher-cost diagnostic radiopharmaceuticals on the Medicare side.
Operationally, the combination of mobile radiology taxonomy and heavy billing for both PET/CT imaging (78815, 78816) and radiotracers (A9595, A9552) implies integrated logistics for tracer supply, patient scheduling, and on-site imaging delivery. Sustaining these services requires handling short-half-life isotopes and coordinating mobile imaging capacity with referral patterns from oncology and other specialties.
The provider’s NPI was enumerated on 2017-08-16 (~9 years ago), indicating nearly a decade of billing history under this registration. Given the concentrated revenue streams and national outlier status on key Medicare PET codes, the organization appears established in its niche but sensitive to shifts in PET/tracer utilization or reimbursement policies.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
4 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 78815 | PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.… | 690 | $1,330 | $916.9K |
| A9595 | Piflufolastat f-18, diagnostic, 1 millicurie | 840 | $480 | $405.1K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 670 | $410 | $278.2K |
| 78816 | The patient is injected with a radiopharmaceutical tracer called FDG (fluoro–deoxyglucose, a radioactive substance containing glucose) about one hour before the imaging is scheduled to begin. The… | 70 | $1,330 | $98.4K |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 4 CPT/HCPCS codes.
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
2 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 78815 | PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.… | 1,300 | $450 | $586.7K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 1,330 | $180 | $242.6K |
How this provider's Medicaid billing volume and revenue compare to other Massachusetts providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Massachusetts median
2 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 78815 | PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.… | 15 | 50 | 630 | $460 | $459.9K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 10 | 30 | 710 | $70 | $70.5K |
Other providers in the same ZIP code as Shields Pet Ct At Berkshire Medical Center LLC, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.